These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37083543)

  • 1. Assessing regulated cell death modalities as an efficient tool for
    Tkachenko A; Onishchenko A; Myasoedov V; Yefimova S; Havranek O
    Nanotoxicology; 2023 Apr; 17(3):218-248. PubMed ID: 37083543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential application of nanomaterials for ferroptosis-based cancer therapy.
    Li Y; Wei X; Tao F; Deng C; Lv C; Chen C; Cheng Y
    Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34038885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of nanotoxicity: generation of reactive oxygen species.
    Fu PP; Xia Q; Hwang HM; Ray PC; Yu H
    J Food Drug Anal; 2014 Mar; 22(1):64-75. PubMed ID: 24673904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine-mediated regulated cell death in cancer immunotherapy.
    Sun Y; Lian T; Huang Q; Chang Y; Li Y; Guo X; Kong W; Yang Y; Zhang K; Wang P; Wang X
    J Control Release; 2023 Dec; 364():174-194. PubMed ID: 37871752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis.
    Tkachenko A; Havránek O
    Folia Biol (Praha); 2023; 69(4):116-126. PubMed ID: 38410969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting regulated cell death in tumor nanomedicines.
    Zeng Q; Ma X; Song Y; Chen Q; Jiao Q; Zhou L
    Theranostics; 2022; 12(2):817-841. PubMed ID: 34976215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of planned cell death of necroptosis in cancer treatment by nanomaterials: Recent advances and future perspectives.
    Sharifi M; Hosseinali SH; Saboury AA; Szegezdi E; Falahati M
    J Control Release; 2019 Apr; 299():121-137. PubMed ID: 30763621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemocompatibility studies in nanotoxicology: Hemolysis or eryptosis? (A review).
    Tkachenko A
    Toxicol In Vitro; 2024 Jun; 98():105814. PubMed ID: 38582230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death.
    Li J; Yi X; Liu L; Wang X; Ai J
    Apoptosis; 2023 Aug; 28(7-8):1198-1215. PubMed ID: 37184582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical mechanisms of the toxicological properties of nanomaterials: generation of intracellular reactive oxygen species.
    Yan L; Gu Z; Zhao Y
    Chem Asian J; 2013 Oct; 8(10):2342-53. PubMed ID: 23881693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis.
    Florean C; Song S; Dicato M; Diederich M
    Free Radic Biol Med; 2019 Apr; 134():177-189. PubMed ID: 30639617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotoxicity: a challenge for future medicine.
    Akçan R; Aydogan HC; Yildirim MŞ; Taştekin B; Sağlam N
    Turk J Med Sci; 2020 Jun; 50(4):1180-1196. PubMed ID: 32283898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterials-induced programmed cell death: Focus on mitochondria.
    Qiao S; Kang Y; Tan X; Zhou X; Zhang C; Lai S; Liu J; Shao L
    Toxicology; 2024 May; 504():153803. PubMed ID: 38616010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment.
    Farzipour S; Zefrei FJ; Bahadorikhalili S; Alvandi M; Salari A; Shaghaghi Z
    Anticancer Agents Med Chem; 2024; 24(8):571-589. PubMed ID: 38275050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
    Nguyen NHA; Falagan-Lotsch P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials meet zebrafish: Toxicity evaluation and drug delivery applications.
    Jia HR; Zhu YX; Duan QY; Chen Z; Wu FG
    J Control Release; 2019 Oct; 311-312():301-318. PubMed ID: 31446084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy.
    Catanzaro E; Feron O; Skirtach AG; Krysko DV
    Front Immunol; 2022; 13():925290. PubMed ID: 35844506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated approach for assessing the in vitro and in vivo redox-related effects of nanomaterials.
    Vardakas P; Skaperda Z; Tekos F; Trompeta AF; Tsatsakis A; Charitidis CA; Kouretas D
    Environ Res; 2021 Jun; 197():111083. PubMed ID: 33775680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.